Dyne Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Dyne Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Dyne Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Dyne Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.7M | 102k | 35.92 |
| 2024-06-30 | $3.4M | 98k | 35.29 |
| 2024-03-31 | $1.5M | 54k | 28.39 |
| 2023-12-31 | $552k | 42k | 13.30 |
| 2023-09-30 | $3.0M | 338k | 8.96 |
| 2023-06-30 | $401k | 36k | 11.25 |
| 2023-03-31 | $309k | 27k | 11.51 |
| 2022-12-31 | $296k | 20k | 14.49 |
| 2022-06-30 | $242k | 35k | 6.85 |
| 2022-03-31 | $268k | 28k | 9.61 |
| 2021-12-31 | $450k | 38k | 11.89 |
| 2021-03-31 | $158k | 10k | 15.50 |
| 2020-12-31 | $134k | 6.4k | 20.95 |